Patient and public involvement in clinical guidelines: International experiences and future perspectives

Quality and Safety in Health Care

Volumn 19, Issue 5, 2010, Pages

  Boivin, Antoine ^a   Currie, Kay ^b   Fervers, Béatrice ^c   Gracia, Javier ^d   James, Marian ^e   Marshall, Catherine ^f   Sakala, Carol ^g   Sanger, Sylvia ^h   Strid, Judi ⁱ   Thomas, Victoria ⁱ   Van Der Weijden, Trudy ^j   Grol, Richard ^a   Burgers, Jako ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b NATIONAL HEALTH AND MEDICAL RESEARCH COUNCIL   (Australia)

^c UNIVERSITÉ DE LYON   (France)

^d Unidad de Evaluacion de Tecnologias Sanitarias   (Spain)

^e AGENCY FOR HEALTHCARE RESEARCH AND QUALITY   (United States)

^f Childbirth Connection ^*

^g Agency for Quality in Medicine   (Germany)

^h National Consumer Advocacy Service   (Germany)

ⁱ NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE   (United Kingdom)

^j MAASTRICHT UNIVERSITY   (Netherlands)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CONSUMER; EDUCATION; HUMAN; INTERNATIONAL COOPERATION; PATIENT PARTICIPATION; PRACTICE GUIDELINE;

CONSUMER PARTICIPATION; EDUCATION; HUMANS; INTERNATIONALITY; PATIENT PARTICIPATION; PRACTICE GUIDELINES AS TOPIC;

EID: 78249261803     PISSN: 14753898     EISSN: 14753901     Source Type: Journal    
DOI: 10.1136/qshc.2009.034835     Document Type: Article

References (42)

1. Grimshaw JM, Thomas RE, MacLennan G, et al. Effectiveness and efficiency of guideline dissemination and implementation strategies. Health Technol Assess 2004;8: 1-72.
2. Grol R, Wensing M, Eccles M. Improving patient care: the implementation of change in clinical practice. New York: Elsevier Butterworth Heinemann, 2005.
3. WHO. Global programme on evidence for health policy. Guidelines for WHO guidelines. Geneva: World Health Organization, 2003.
4. Schunemann HJ, Fretheim A, Oxman AD. Improving the use of research evidence in guideline development: 10. Integrating values and consumer involvement. Health Res Policy Syst 2006;4: 22.
5. The AGREE collaboration. Appraisal of Guidelines for Research amp; Evaluation (AGREE) instrument. 2001. http://www.agreetrust.org (accessed 10 Jul 2007).
6. Krahn M, Naglie G. The next step in guideline development: incorporating patient preferences. JAMA 2008;300: 436-8.
7. Nilsen ES, Myrhaug HT, Johansen M, et al. Methods of consumer involvement in developing healthcare policy and research, clinical practice guidelines and patient information material. Issue 3. Cochrane Database Syst Rev 2006: CD004563. doi: 10.1002/14651858.CD004563.pub2
8. Boivin A, Green J, van der Meulen J, et al. Why consider patients' preferences? A discourse analysis of clinical practice guideline developers. Med Care 2009;47: 908-15.
9. Ollenschlager G, Marshall C, Qureshi S, et al. Improving the quality of health care: using international collaboration to inform guideline programmes by founding the Guidelines International Network (GIN). Qual Saf Health Care 2004;13: 455-60.
10. Buse K, Mays N, Walt G. Making health policy, London: Open University Press, 2006.
11. Rowe G, Frewer LJ. A typology of public engagement mechanisms. Sci Technol Human Values 2005;30: 251.
12. Boivin A, Currie K, Burgers J, et al eds. Patient and public involvement in guidelines (Part 1): Sharing international experiences. 5th International G-I-N Conference 1-3 October 2008, Helsinki: Finland.
13. Boivin A, Burgers J, Fervers B, et al on behalf of the Guideline International Network Patient and Public Involvement Working Group, eds. Patient and public involvement in guidelines (Part 2): Defining strategies for the future. 5th International G-I-N Conference 1-3 October 2008, Helsinki: Finland.
14. Green J, Thorogood N. Qualitative methods for health research. London: SAGE, 2004.
15. Gandjour A, Westenhofer J, Wirth A, et al. Development process of an evidence- based guideline for the treatment of obesity. Int J Qual Health Care 2001;13: 325-32.
16. Raats CJ, van Veenendaal H, Versluijs MM, et al. A generic tool for development of decision aids based on clinical practice guidelines. Patient Educ Couns 2008;73: 413-17.
17. O'Connor AM, Legare F, Stacey D. Risk communication in practice: the contribution of decision aids. BMJ 2003;327: 736-40.
18. Cabana MD, Rand CS, Powe NR, et al. Why don't physicians follow clinical practice guidelines?: a framework for improvement. JAMA 1999;282: 1458-65.
19. Lugtenberg M, Zegers-van Schaick J, Westert G, et al. Why don't physicians adhere to guideline recommendations in practice? An analysis of barriers among Dutch general practitioners. Implement Sci 2009;4: 54.
20. Burgers JS, Grol R, Klazinga NS, et al. Towards evidence-based clinical practice: an international survey of 18 clinical guideline programs. Int J Qual Health Care 2003;15: 31-45. (Pubitemid 36305560)
21. Graham ID, Beardall S, Carter AO, et al. The state of the science and art of practice guidelines development, dissemination and evaluation in Canada. J Eval Clin Pract 2003;9: 195-202.
22. Carretier J, Bataillard A, Fervers B, et al, eds. From clinical practice guidelines to patient information: the French approach for patient involvement. 4th Guidleine International Network Conference 24 August 2007, Toronto: Canada.
23. van de Bovenkamp HM, Trappenburg MJ. Reconsidering patient participation in guideline development. Health Care Anal 2009;17: 198-216.
24. Owens DK. Patient preferences and the development of practice guidelines. Spine 1998;23: 1073-9.
25. Bastian H. Raising the standard: practice guidelines and consumer participation. Int J Qual Health Care 1996;8: 485-90.
26. McCormack JP, Loewen P. Adding 'value' to clinical practice guidelines. Can Fam Physician 2007;53: 1326-7.
27. Nease RF Jr, Owens DK. A method for estimating the cost-effectiveness of incorporating patient preferences into practice guidelines. Med Decis Making 1994;14: 382-92.
28. Dowie J, Wildman M. Choosing the surgical mortality threshold for high risk patients with stage la non-small cell lung cancer: insights from decision analysis. Thorax 2002;57: 7-10.
29. Sheridan SL, Harris RP, Woolf SH. Shared decision making about screening and chemoprevention. a suggested approach from the U.S. Preventive Services Task Force. Am J Prev Med 2004;26: 56-66.
30. Mitton C, Smith N, Peacock S, et al. Public participation in health care priority setting: a scoping review. Health Policy 2009;91 : 219-28.
31. Thomas V. Involving patients and carers in developing national clinical practice guidelines-an evaluation. London: Open University, 2008.
32. Davies C, Wetherell M, Barnett E, et al. Citizens at the centre: deliberative participation in healthcare decisions. Sociol Health Illn 2007;29: 787-8.
33. Jarrett L. A report on a study to evaluate patient/carer membership of the first NICE Guideline Development Groups. London: National lnstitute of Clinical Excellence Patient lnvolvement Unit, 2004.
34. Murphy MK, Black NA, Lamping DL, et al. Consensus development methods, and their use in clinical guideline development. London: Health Technology Assessment, 1998 Contract No.: 3.
35. Legare F, Boivin A, van der Weijden T, et al. A knowledge synthesis of patient and public involvement in clinical practice guidelines: study protocol. Implement Sci 2009;4: 30.
36. Rosener JB. User-oriented evaluation: a new way to view citizen participation. J Appl Behav Sci 1981;17: 583.
37. Abelson J, Gauvin FP. Assessing the impacts of public participation: concepts, evidence and policy implications. 2006 http://www.cprn.com (accessed Feb 2009).
38. Kraemer JD, Gostin LO. Science, politics, and values: the politicization of professional practice guidelines. JAMA 2009;301: 665-7.
39. Norheim OF. Healthcare rationing-are additional criteria needed for assessing evidence based clinical practice guidelines? BMJ 1999;319: 1426-9.
40. Saarni SI, Gylling HA. Evidence based medicine guidelines: a solution to rationing or politics disguised as science? J Med Ethics 2004;30: 171-5.
41. Chalmers I. The Alzheimer's Society, drug manufacturers, and public trust. BMJ 2007;335: 400.
42. Dyer O. High court upholds NICE decision to limit treatments for Alzheimer's disease. BMJ 2007;335: 319.